Načítá se...
Complete heart block associated with Remdesivir in COVID-19: a case report
BACKGROUND: Since the pandemic began in 2020, Remdesivir has been widely used for the treatment of coronavirus disease-2019 (COVID-19). Here, we describe a case of a patient with COVID-19 who developed transient complete atrioventricular (AV) block and bradycardia after initiating treatment with Rem...
Uloženo v:
| Vydáno v: | Eur Heart J Case Rep |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247739/ https://ncbi.nlm.nih.gov/pubmed/34222786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcr/ytab200 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|